Physician profile
Katrina Britt
NPI 1790095495
$1,856.39
in general payments reported to CMS, 2019-2025
13 companies · $494 in 2025
The $494 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.27 · 2022: $137 · 2023: $572 · 2024: $606 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,670.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $836.63 | 2023-2025 | Orgovyx |
| Boston Scientific Corporation | $259.81 | 2023-2025 | Spaceoar Vue System - 10ml, Therasphere Administration Set |
| Novocure INC. | $227.56 | 2023-2025 | Optune, Optune Gio |
| Myovant Sciences INC. | $129.89 | 2021-2022 | |
| Tactile Systems Technology INC | $108.23 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Teleflex LLC | $69.99 | 2024-2025 | Barrigel |
| Merck Sharp & Dohme LLC | $65.87 | 2024-2025 | Keytruda, Keytruda Qlex |
| Novartis Pharmaceuticals Corporation | $56.95 | 2024-2025 | |
| Springworks Therapeutics, INC. | $25.96 | 2025 | Ogsiveo |
| Monteris Medical Corporation | $21.62 | 2022 | |
| Sobi, INC | $19.94 | 2025 | |
| Progenics Pharmaceuticals, INC. | $18.12 | 2022 | |
| Reflexion Medical, INC. | $15.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Britt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.